These compounds may interact with:
Metabotropic glutamate receptor 5
Potentially involved in: attention deficit hyperactivity disorder; kidney cancer; substance-related disorder; carcinoma; acquired immunodeficiency syndrome; fragile x syndrome; schizophrenia; autistic disorder; parkinson's disease; intellectual disability; epilepsy; hypotrichosis 1; toxic encephalopathy; gastroesophageal reflux disease; major depressive disorder; alzheimer's disease; alcohol dependence; amyotrophic lateral sclerosis; obsessive-compulsive disorder; huntington's disease
Disease data sourced from Pharos.
